313份注射液药品说明书标注信息调查分析

doi:10.19803/j.1672-8629.2021.07.15

中国药物警戒 ›› 2021, Vol. 18 ›› Issue (7): 669-673.
DOI: 10.19803/j.1672-8629.2021.07.15

313份注射液药品说明书标注信息调查分析

张永恒, 韩晨, 杨宵, 韩秀奇, 袁红昌, 邓智建^*

新乡医学院第一附属医院药学部,河南新乡453100

收稿日期:2019-12-23 出版日期:2021-07-15 发布日期:2021-07-23
通讯作者: ^*邓智建,男,硕士,主任药师,临床药学。E-mail：2578001779@qq.com
作者简介:张永恒, 男,本科, 副主任药师,临床合理用药研究。
基金资助:
中国健康促进基金项目（20160021）

Analysis of 313 Instructions for Injectable Drugs

ZHANG Yongheng, HAN Chen, YANG Xiao, HAN Xiuqi, YUAN Hongchang, DENG Zhijian^*

Department of Pharmacy, the First Affiliated Hospital of Xinxiang Medical University, Xinxiang Henan 453100, China

Received:2019-12-23 Online:2021-07-15 Published:2021-07-23

摘要/Abstract

摘要： 目的分析注射液药品说明书信息标注情况,为规范完善说明书内容提供参考。方法收集313份注射液药品说明书,统计分析项目内容,比较进口和国产注射液药品说明书的标注率以及不同企业生产同一种注射液药品说明书标注的差异性。结果与国产相比,进口注射液药品说明书中的药物相互作用、药物过量、毒理研究等标注率较高,差异有统计学意义（P<0.05）;不同企业生产同一种注射液药品说明书标注的差异率为42.86%（9/21）。结论进口注射液药品说明书中部分项目的标注率高于国产药品说明书;不同企业同一种注射液药品说明书的标注存在差异性。

关键词: 注射液, 药品说明书, 完整性, 差异性, 合理用药

Abstract: Objective To investigate the labeled information in the instructions of injectable drugs and provide reference for the improvement of instructions. Methods A total of 313 instructions for injectable drugs used in the First Affiliated Hospital of Xinxiang Medical University from January 2018 to November 2019 were collected before the items and contents in the instructions were statistically analyzed. The labeling rates were compared between imported drugs and home-made ones, and the difference in the specifications of the same type of injectable drug by different manufacturers was also studied. Results The labeling rate of drug interactions, drug overdose and toxicology in the instructions of imported drugs was higher than that of domestic drugs, with statistically significant differences (P<0.05). The difference rate in the specifications of the same type of drug produced by different enterprises was 42.86% (9/21). Conclusion The labeling rate of instructions of imported drugs is higher than that of home-made drugs. There are differences in the specifications of the same type of injectable drug produced by different enterprises.

Key words: injection, instructions of drugs, integrity, difference, rational use of drugs

中图分类号:

张永恒, 韩晨, 杨宵, 韩秀奇, 袁红昌, 邓智建. 313份注射液药品说明书标注信息调查分析[J]. 中国药物警戒, 2021, 18(7): 669-673.

ZHANG Yongheng, HAN Chen, YANG Xiao, HAN Xiuqi, YUAN Hongchang, DENG Zhijian. Analysis of 313 Instructions for Injectable Drugs[J]. Chinese Journal of Pharmacovigilance, 2021, 18(7): 669-673.

参考文献

[1] Shah TJ, Moshirfar M."Doctor, I have a sulfa allergy": clarifying the myths of cross-reactivity[J]. Ophthalmology and Therapy, 2018, 7(2): 211-215.
[2] Mcconeghy KW, Caffrey AR, Morrill HJ, et al.Are non-allergic drug reactions commonly documented as medication“allergies”? a national cohort of veterans' admissions from 2000 to 2014[J]. Pharmacoepidemiology and Drug Safety, 2017, 26(4): 472-476.
[3] He XJ, Ji Y, Li XB, et al.Safety information for pregnant women in drug instructions and drug information databases[J]. Practical Pharmacy and Clinical Remedies(实用药物与临床), 2018, 21(9): 1077-1080.
[4] Wang XY, Su WW, Ding H, et al.Problems of clinical use in pediatric drug and countermeasures analysis in China[J]. Chinese Pharmacy(中国药房), 2019, 30(2): 149-153.
[5] Wang RQ, Huo YF, Xie YJ, et al.Retrospective analysis of 530 cases of new/severe pediatric adr in shandong province during 2016~2017[J]. Chinese Pharmacy(中国药房), 2019, 30(1): 115-119.
[6] Su XD, Fang S, Fu XD.Practice and enlightenment of patient medication guide in foreign Countries such as Europe and America[J]. Herald of Medicine(医药导报), 2018, 37(2): 265-267.
[7] Fu SY, Yang Y, Yu JR.Comparison of laws and regulations of drug instructions management between China and the United States of America[J]. Herald of Medicine(医药导报), 2018, 37(10): 1291-1294.
[8] Wu TT.Retrospective analysis of adverse drug reaction of shuxuening injection in Xi'an from 2013 to 2017[J]. Herald of Medicine(医药导报), 2019, 38(1): 49-53.
[9] State Food and Drug Administration of the People's Republic of China. Provisions on the administration of drug instructions and labels [EB/OL].(2006-03-16)[2019-11-20]. http://www.gov.cn/ziliao/flfg/2006-03/16/ content_228465.htm.
[10] State Food and Drug Administration of the People's Republic of China. Notice concerning the issuance of specifications and rules for the specifications of chemical drugs and biological products(National Food and Drug Administration notes[2006]202号)[EB/OL].(2006-05-10)[2019-11-20].http://www.nmpa.gov.cn/ WS04/CL2196/323547.html.
[11] Zhang H, Gu YX.Literature review of 141 cases of adverse drug reactions induced by simvastatin[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2019, 16(8): 487-491.
[12] Zhang SZ, Huang WJ.Clinical efficacy and adverse reaction of torasemide combined with bisoprolol in the treatment of patients with essential hypertension complicated with systolic heart failure[J]. Chinese Journal of Pharmacovigilance(中国药物警戒), 2019, 16(8): 467-472.
[13] Wei J, Cai J, Li M, et al.Statistical analysis of sulfonamide allergy item annotation in drug instructions of commonly-used sulfonylureas at home and abroad[J]. Chinese Pharmacy(中国药房), 2019, 30(4): 538-541.
[14] Xu J, Zheng XX, Liu HF, et al.A survey on attention about drug labels among outpatients[J]. Chinese Remedies & Clinics(中国药物与临床), 2019, 19(4): 543-545.
[15] Herber OR, Gies V, Schwappach D, et al.Patient information leaflets: informing or frightening? a focus group study exploring patients’emotional reactions and subsequent behavior towards package leaflets of commonly prescribed medications in family practices[J]. BMC Family Practice, 2014, 15(1): 1-8.
[16] Sato T.What is a medication guide suits patients' needs?[J]. Journal of the Pharmaceutical Society of Japan, 2015, 135(2): 297-306.
[17] Benjamin B, Thomas V, Carole L, et al.Safety and drinking outcomes among patients with comorbid alcohol dependence and borderline personality disorder treated with high-dose baclofen: a comparative cohort study[J]. International Clinical Psychopharmacology, 2015, 30(1): 49-53.
[18] Rolland B, Deheul S, Danel T, et al.Temporary recommendation for use on off-label baclofen: viewpoint of prescribers of the CAMTEA System[J]. Therapies, 2015, 70(2): 235-238.

313份注射液药品说明书标注信息调查分析

Analysis of 313 Instructions for Injectable Drugs

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	范凯凯, 王聪, 刘洪峰, 王西勇. 临床药师对某院丙氨酰谷氨酰胺注射液应用干预分析[J]. 中国药物警戒, 2024, 21(2): 181-184.
[2]	张建, 方慧华. 某院活血化瘀类中药注射剂使用评价标准建立的探索[J]. 中国药物警戒, 2024, 21(2): 185-189.
[3]	李应芬, 韩雷. 319例注射用脑蛋白水解物药品不良反应报告分析[J]. 中国药物警戒, 2024, 21(2): 195-198.
[4]	陈玉艳, 张明霞, 张涛, 张晋. 斯鲁利单抗注射液致间质性肺炎不良反应1例分析[J]. 中国药物警戒, 2024, 21(2): 213-215.
[5]	熊玮仪, 任经天. 抗肿瘤药说明书安全性信息上市后修订的考虑要点[J]. 中国药物警戒, 2024, 21(1): 94-97.
[6]	史卜文, 李利寻, 谢雁鸣, 王志飞, 王淇. 真实世界喜炎平注射液治疗3846例细菌性肠道感染患者临床用药特征分析[J]. 中国药物警戒, 2023, 20(9): 1017-1021.
[7]	黎杏仁, 沈爱宗, 苏丹. 质子泵抑制剂预防胆胰外科围术期应激性黏膜病变的合理性评价[J]. 中国药物警戒, 2023, 20(9): 1022-1026.
[8]	史香芬, 孙志勇, 张旭锋, 卢晓静, 杜书章, 张晓坚. 基于智能信息管理系统的门诊麻精药品全流程管理[J]. 中国药物警戒, 2023, 20(8): 899-903.
[9]	霍艳飞, 田月洁, 许莉莉, 谢彦军, 常虹, 孙春晓, 李霞. 535例氢溴酸高乌甲素制剂新的和严重的药品不良反应报告分析[J]. 中国药物警戒, 2023, 20(8): 921-926.
[10]	孟康康, 刘赛月. 辅酶Q10注射剂上市后安全性分析[J]. 中国药物警戒, 2023, 20(7): 795-798.
[11]	刘婧, 夏亮, 张世杰. 1例多元药物过敏急性胰腺炎患者行药物激发试验的药学监护[J]. 中国药物警戒, 2023, 20(7): 822-824.
[12]	秦桂兰, 周木子, 冀召帅, 毛乾泰, 艾超. 司美格鲁肽注射液致急性便秘1例分析[J]. 中国药物警戒, 2023, 20(7): 833-835.
[13]	王国华, 黎晓蕾, 刘希萍, 董毅智, 臧琛, 徐鸿, 田纪祥, 赵静. 痰热清注射液雾化吸入治疗慢性阻塞性肺疾病Meta分析[J]. 中国药物警戒, 2023, 20(5): 544-552.
[14]	范秀丛, 董晓慧, 陈丹霞, 鲍思蔚, 马雅斌. 1例妊娠期艰难梭菌感染伴尿路感染患者的药学监护[J]. 中国药物警戒, 2023, 20(5): 579-582.
[15]	杜莹, 赵晓晓, 谢雁鸣, 余小康. 基于真实世界使用榄香烯乳状注射液影响肝功能的倾向性评分分析[J]. 中国药物警戒, 2023, 20(2): 191-195.